Evidence map›Paper›PMID 29683381›Full record

ArticleRNA biology2018

Pseudouridines have context-dependent mutation and stop rates in high-throughput sequencing.

Katherine I Zhou, Wesley C Clark, David W Pan, Matthew J Eckwahl, Qing Dai, Tao Pan

Abstract read
In one paragraph

Article in RNA biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  6. Article
  7. Science advances · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Benchmarking RNA Editing Detection Tools.Biotech (Basel (Switzerland)) · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katherine I Zhoua Medical Scientist Training Program , The University of Chicago , Chicago , Illinois , USA.ORCID 0000-0001-6442-0475
Wesley C Clarkb Department of Biochemistry and Molecular Biology , The University of Chicago , Chicago , Illinois , USA.
David W Panb Department of Biochemistry and Molecular Biology , The University of Chicago , Chicago , Illinois , USA.
Matthew J Eckwahlb Department of Biochemistry and Molecular Biology , The University of Chicago , Chicago , Illinois , USA.
Qing Daic Department of Chemistry , The University of Chicago , Chicago , Illinois , USA.
Tao Panb Department of Biochemistry and Molecular Biology , The University of Chicago , Chicago , Illinois , USA.

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI MARK W. LINGEN · 1985 to 2026
$122.1M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
Transcriptome-wide base-resolution sequencing of pseudouridine in human normal and AD brain tissues-CEGS Admin supplement 2020-2021RM1HG008935 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2016 to 2025
$24.4M
MULTIDISCIPLINARY CARDIAC SCIENCEST32HL007381 · NHLBI · UNIVERSITY OF CHICAGO · PI JEANNE M DECARA, Yoav Gilad · 1985 to 2026
$12.5M
Investigation of 5-hmC, 5fC and 5-caC Modifications in Genome DNAK01HG006699 · NHGRI · UNIVERSITY OF CHICAGO · PI DAI, QING · 2012 to 2016
$702k
Role of m6A in HNRNPG protein localization and HNRNPG-regulated alternative splicingF30GM120917 · NIGMS · UNIVERSITY OF CHICAGO · PI ZHOU, KATHERINE ISMEI · 2016 to 2018
$147k
NCI NIH HHS P30 CA014599NHGRI NIH HHS K01 HG006699NHGRI NIH HHS RM1 HG008935NHLBI NIH HHS T32 HL007381NIGMS NIH HHS F30 GM120917NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

The abundant RNA modification pseudouridine (Ψ) has been mapped transcriptome-wide by chemically modifying pseudouridines with carbodiimide and detecting the resulting reverse transcription stops in high-throughput sequencing. However, these methods have limited sensitivity and specificity, in part due to the use of reverse transcription stops. We sought to use mutations rather than just stops in sequencing data to identify pseudouridine sites. Here, we identify reverse transcription conditions that allow read-through of carbodiimide-modified pseudouridine (CMC-Ψ), and we show that pseudouridines in carbodiimide-treated human ribosomal RNA have context-dependent mutation and stop rates in high-throughput sequencing libraries prepared under these conditions. Furthermore, accounting for the context-dependence of mutation and stop rates can enhance the detection of pseudouridine sites. Similar approaches could contribute to the sequencing-based detection of many RNA modifications.

Indexed as

High-Throughput Nucleotide SequencingRNA Processing, Post-TranscriptionalAptamers, NucleotideCME-CarbodiimideDNA, ComplementaryHEK293 CellsHumansMutationPseudouridineReverse TranscriptionRNA-Directed DNA PolymeraseRNA, RibosomalSequence AlignmentAptamers, NucleotideCME-CarbodiimideDNA, ComplementaryPseudouridineRNA-Directed DNA PolymeraseRNA, RibosomalHigh-throughput sequencingpseudouridineRNA modification

Identifiers

PMID29683381
PMCPMC6161689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.